Transaortic Medical
TransAortic Medical is dedicated to developing innovative medical devices that provide safe and effective solutions to protect patients undergoing structural heart interventions. Their featured transShield Embolic Protection System is designed to reduce the incidence of stroke during Transcatheter Aortic Valve Replacement (TAVR) procedures by capturing and removing embolic debris, significantly reducing the risk of stroke.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Catheter-delivered embolic protection system for structural heart procedures
A catheter-based embolic protection system designed to capture and remove embolic debris during structural heart interventions, providing protection to cerebral and peripheral vasculature and designed for insertion via standard transfemoral access.
transShield Embolic Protection System
The transShield Embolic Protection System is designed to reduce the incidence of stroke during Transcatheter Aortic Valve Replacement (TAVR) procedures by capturing and removing embolic debris.
Catheter-delivered embolic protection system for structural heart procedures
A catheter-based embolic protection system designed to capture and remove embolic debris during structural heart interventions, providing protection to cerebral and peripheral vasculature and designed for insertion via standard transfemoral access.
transShield Embolic Protection System
The transShield Embolic Protection System is designed to reduce the incidence of stroke during Transcatheter Aortic Valve Replacement (TAVR) procedures by capturing and removing embolic debris.
Services
Support for device concept development, engineering, and advancement toward regulatory approval and commercial launch.
Regulatory submission preparation, clinical program oversight, and quality affairs support for medical device products.
Design and participation in clinical studies to evaluate device impact on clinical endpoints such as stroke reduction.
Support for device concept development, engineering, and advancement toward regulatory approval and commercial launch.
Regulatory submission preparation, clinical program oversight, and quality affairs support for medical device products.
Design and participation in clinical studies to evaluate device impact on clinical endpoints such as stroke reduction.
Expertise Areas
- Embolic protection for structural heart interventions
- Catheter-based transfemoral device delivery
- Clinical trial design and evidence generation for device outcomes
- Medical device development and commercialization
Key Technologies
- Embolic protection devices
- Catheter-based transfemoral delivery
- Repositionable intravascular filters
- Device capture and retrieval mechanisms
News & Updates
A recent clinical study with 3,000 patients demonstrated that using the embolic protection device during TAVR significantly reduces the risk of stroke, including a 21% relative risk reduction in all stroke and a 60% reduction in disabling stroke.
A recent clinical study with 3,000 patients demonstrated that using the embolic protection device during TAVR significantly reduces the risk of stroke, including a 21% relative risk reduction in all stroke and a 60% reduction in disabling stroke.